Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11226631 | PMC |
| http://dx.doi.org/10.1038/s41433-024-03055-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dropless Cataract Surgery: A Review of the Literature.
Int Ophthalmol Clin
April 2025
Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA.
Cataract surgery is one of the most performed surgeries worldwide, often necessitating postoperative eye drops to manage infection, inflammation, and pain. However, complex regimens, patient adherence challenges, and environmental concerns have led to growing interest in "dropless" cataract surgery, which eliminates or reduces the need for postoperative drops by delivering medications intraoperatively through injections or drug-eluting implants. This review provides an overview of dropless cataract surgery, focusing on common medications used including antibiotics, steroids, nonsteroidal anti-inflammatory drugs, and intraocular pressure medications.
View Article and Find Full Text PDFUpdate on Retinal Drug Safety: Proceedings of the ASRS ReST Committee Webinar Part 1.
J Vitreoretin Dis
August 2024
Austin Retina Associates, Austin, TX, USA.
To review the first Research and Safety in Therapeutics (ReST) Committee webinar and summarize the most current recommendations regarding diagnosis and management. The ReST Committee is comprised of members of the American Society of Retina Surgeons (ASRS). At regular internal meetings, safety issue reports from the website are reviewed.
View Article and Find Full Text PDFDropless Cataract Surgery: The Effect of Intracameral Phenylephrine/Ketorolac Infusion as a Single Agent on Postoperative Outcomes.
Cureus
June 2024
Surgical Ophthalmology, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, USA.
Objective The objective of this study was to assess the feasibility of using an intracameral phenylephrine/ketorolac infusion during cataract surgery as a single agent to prevent postoperative pain, inflammation, and other complications. Methods A prospective, single-group feasibility study was conducted in which phenylephrine/ketorolac infusion was administered during cataract surgery and no perioperative topical drops were initially prescribed. Patients underwent optical coherence tomography, corrected distance visual acuity testing, and slit lamp biomicroscopy examination at perioperative visits, during which they also reported symptoms of pain, irritation, and/or photophobia.
View Article and Find Full Text PDFCost analysis of dropless cataract surgery prophylaxis with intracameral antibiotics and subconjunctival steroids.
J Cataract Refract Surg
December 2024
From the Department of Ophthalmology, New York University Grossman School of Medicine, New York, New York (Massa, Patil, Parikh); Cheyenne Eye Clinic and Surgery Center, Cheyenne, Wyoming (Smits); Department of Ophthalmology, Yale New Haven Health, New Haven, Connecticut (Nguyen); The Eye Care Group
Purpose: To determine whether dropless, injection-based cataract surgery prophylaxis with intracameral antibiotic and subconjunctival steroid may reduce healthcare system costs and patient out-of-pocket costs compared with topical medication regimens.
Setting: U.S.
Transzonular moxifloxacin and dexamethasone delivery in phacoemulsification: A novel dropless regimen.
Indian J Ophthalmol
August 2024
Institute of Ophthalmology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
Purpose: To assess the safety and efficacy of transzonular moxifloxacin and dexamethasone versus standard postoperative topical drug regimen in phacoemulsification.
Design: Nonrandomized prospective study.
Methods: The study included 100 eyes of 100 age and gender-matched individuals with senile cataract undergoing routine phacoemulsification.